Abstract
Radiofrequency catheter ablation (RFCA) is the first-line therapy for treatment of drug refractory ventricular arrhythmias (VAs), however, creating a safe, transmural lesion can be difficult. Ethanol in the arterial system has been used as an adjunctive therapy to RFCA since 1986, but with limited use due to technical and efficacy limitations. Venous ethanol is emerging as powerful alternative.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 743-756 |
| Number of pages | 14 |
| Journal | Cardiac Electrophysiology Clinics |
| Volume | 14 |
| Issue number | 4 |
| DOIs | |
| State | Published - Dec 2022 |
Keywords
- Ethanol
- Radiofrequency catheter ablation
- Transcoronary ethanol ablation
- Ventricular arrhythmia
- Ventricular tachycardia
- VT ablation
- Tachycardia, Ventricular
- Coronary Vessels/surgery
- Humans
- Ethanol/therapeutic use
- Treatment Outcome
- Catheter Ablation
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
- Physiology (medical)
Fingerprint
Dive into the research topics of 'Chemical Ablation of Ventricular Tachycardia Using Coronary Arterial and Venous Systems'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS